This Stock Offers Consistent International Growth
For a low-beta winner with international exposure, it’s an outstanding pick.
Read MorePosted by Louis Navellier and the InvestorPlace Research Staff | Oct 1, 2020
For a low-beta winner with international exposure, it’s an outstanding pick.
Read MorePosted by Louis Navellier and the InvestorPlace Research Staff | Sep 26, 2020
There are too many positives to hold it down for long.
Read MorePosted by Louis Navellier and the InvestorPlace Research Staff | Sep 16, 2020
If you’ve been sitting on the sidelines to buy, now’s as good an entry point as you’re probably going to get in the near future.
Read MorePosted by Louis Navellier and the InvestorPlace Research Staff | Sep 12, 2020
Its pullback is an opportunity that shouldn’t be missed.
Read MorePosted by Louis Navellier and the InvestorPlace Research Staff | Sep 11, 2020
The pandemic isn’t the only reason you should be looking at pharmaceutical stocks. Here are six pharma names to buy that will carry your portfolio boldly into the future.
Read More